相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Biochemical alterations associated with ALS
Kay A. Lawton et al.
AMYOTROPHIC LATERAL SCLEROSIS (2012)
Glucose metabolism and pancreatic defects in spinal muscular atrophy
Melissa Bowerman et al.
ANNALS OF NEUROLOGY (2012)
Plasma Biomarkers Associated With the Apolipoprotein E Genotype and Alzheimer Disease
Holly D. Soares et al.
ARCHIVES OF NEUROLOGY (2012)
Severe neuromuscular denervation of clinically relevant muscles in a mouse model of spinal muscular atrophy
Karen K. Y. Ling et al.
HUMAN MOLECULAR GENETICS (2012)
Human Axonal Survival of Motor Neuron (a-SMN) Protein Stimulates Axon Growth, Cell Motility, C-C Motif Ligand 2 (CCL2), and Insulin-like Growth Factor-1 (IGF1) Production
Denise Locatelli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Age at Disease Onset Predicts Likelihood and Rapidity of Growth Failure Among Infants and Young Children With Spinal Muscular Atrophy Types 1 and 2
Douglas M. Sproule et al.
JOURNAL OF CHILD NEUROLOGY (2012)
IPLEX Administration Improves Motor Neuron Survival and Ameliorates Motor Functions in a Severe Mouse Model of Spinal Muscular Atrophy
Michela Murdocca et al.
MOLECULAR MEDICINE (2012)
Machine learning algorithms to classify spinal muscular atrophy subtypes
Tuhin Srivastava et al.
NEUROLOGY (2012)
Neuroscience Networking: Linking Discovery to Drugs
Jill Heemskerk et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Analysis of the Fibroblast Growth Factor System Reveals Alterations in a Mouse Model of Spinal Muscular Atrophy
Niko Hensel et al.
PLOS ONE (2012)
Candidate Proteins, Metabolites and Transcripts in the Biomarkers for Spinal Muscular Atrophy (BforSMA) Clinical Study
Richard S. Finkel et al.
PLOS ONE (2012)
Evaluation of SMN Protein, Transcript, and Copy Number in the Biomarkers for Spinal Muscular Atrophy (BforSMA) Clinical Study
Thomas O. Crawford et al.
PLOS ONE (2012)
Evaluation of Peripheral Blood Mononuclear Cell Processing and Analysis for Survival Motor Neuron Protein
Dione T. Kobayashi et al.
PLOS ONE (2012)
Plasma Epidermal Growth Factor Levels Predict Cognitive Decline in Parkinson Disease
Alice S. Chen-Plotkin et al.
ANNALS OF NEUROLOGY (2011)
Observational Study of Spinal Muscular Atrophy Type 2 and 3 Functional Outcomes Over 1 Year
Petra Kaufmann et al.
ARCHIVES OF NEUROLOGY (2011)
ETS-domain transcription factor Elk-1 mediates neuronal survival: SMN as a potential target
Ozlem Demir et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Extracellular Matrix Functions During Neuronal Migration and Lamination in the Mammalian Central Nervous System
Santos J. Franco et al.
DEVELOPMENTAL NEUROBIOLOGY (2011)
Combination of SMN Trans-Splicing and a Neurotrophic Factor Increases the Life Span and Body Mass in a Severe Model of Spinal Muscular Atrophy
Monir Shababi et al.
HUMAN GENE THERAPY (2011)
HuD interacts with survival motor neuron protein and can rescue spinal muscular atrophy-like neuronal defects
Lisa Hubers et al.
HUMAN MOLECULAR GENETICS (2011)
Increased IGF-1 in muscle modulates the phenotype of severe SMA mice
Marta Bosch-Marce et al.
HUMAN MOLECULAR GENETICS (2011)
Reversible molecular pathology of skeletal muscle in spinal muscular atrophy
Chantal A. Mutsaers et al.
HUMAN MOLECULAR GENETICS (2011)
The spinal muscular atrophy disease protein SMN is linked to the rho-kinase pathway via profilin
Anna Noelle et al.
HUMAN MOLECULAR GENETICS (2011)
Biomarkers in Rare Disorders: The Experience with Spinal Muscular Atrophy
Francesco D. Tiziano et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2011)
Muscle Volume Estimation by Magnetic Resonance Imaging in Spinal Muscular Atrophy
Douglas M. Sproule et al.
JOURNAL OF CHILD NEUROLOGY (2011)
Prolactin increases SMN expression and survival in a mouse model of severe spinal muscular atrophy via the STAT5 pathway
Faraz Farooq et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Identification of a Panel of Novel Serum Osteoarthritis Biomarkers
Patricia Fernandez-Puente et al.
JOURNAL OF PROTEOME RESEARCH (2011)
Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model
Yimin Hua et al.
NATURE (2011)
A screen for regulators of survival of motor neuron protein levels
Nina R. Makhortova et al.
NATURE CHEMICAL BIOLOGY (2011)
SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy
E. Pegoraro et al.
NEUROLOGY (2011)
Utility of Survival Motor Neuron ELISA for Spinal Muscular Atrophy Clinical and Preclinical Analyses
Dione T. Kobayashi et al.
PLOS ONE (2011)
SMA CARNI-VAL TRIAL PART II: A Prospective, Single-Armed Trial of L-Carnitine and Valproic Acid in Ambulatory Children with Spinal Muscular Atrophy
John T. Kissel et al.
PLOS ONE (2011)
Amyotrophic Lateral Sclerosis Multiprotein Biomarkers in Peripheral Blood Mononuclear Cells
Giovanni Nardo et al.
PLOS ONE (2011)
T-cadherin (Cdh13) in association with pancreatic β-cell granules contributes to second phase insulin secretion
Bjoern Tyrberg et al.
ISLETS (2011)
Proteomics of skeletal muscle differentiation, neuromuscular disorders and fiber aging
Kay Ohlendieck
EXPERT REVIEW OF PROTEOMICS (2010)
CHARACTERIZING SPINAL MUSCULAR ATROPHY WITH ELECTRICAL IMPEDANCE MYOGRAPHY
Seward B. Rutkove et al.
MUSCLE & NERVE (2010)
COMPOUND MUSCLE ACTION POTENTIAL AND MOTOR FUNCTION IN CHILDREN WITH SPINAL MUSCULAR ATROPHY
Aga Lewelt et al.
MUSCLE & NERVE (2010)
Adiposity is increased among high-functioning, non-ambulatory patients with spinal muscular atrophy
Douglas M. Sproule et al.
NEUROMUSCULAR DISORDERS (2010)
SMA CARNI-VAL Trial Part I: Double-Blind, Randomized, Placebo-Controlled Trial of L-Carnitine and Valproic Acid in Spinal Muscular Atrophy
Kathryn J. Swoboda et al.
PLOS ONE (2010)
Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes Mellitus
Joshua J. Neumiller et al.
PHARMACOTHERAPY (2010)
Conserved Genes Act as Modifiers of Invertebrate SMN Loss of Function Defects
Maria Dimitriadi et al.
PLOS GENETICS (2010)
Identifying Early Markers of Alzheimer's Disease using Quantitative Multiplex Proteomic Immunoassay Panels
Holly D. Soares et al.
BIOMARKERS IN BRAIN DISEASE (2009)
Weighted gene co-expression network analysis of the peripheral blood from Amyotrophic Lateral Sclerosis patients
Christiaan G. J. Saris et al.
BMC GENOMICS (2009)
Different atrophy-hypertrophy transcription pathways in muscles affected by severe and mild spinal muscular atrophy
Caterina Millino et al.
BMC MEDICINE (2009)
Bone loss in survival motor neuron (Smn(-/-) SMN2) genetic mouse model of spinal muscular atrophy
Srinivasan Shanmugarajan et al.
JOURNAL OF PATHOLOGY (2009)
APPLYING PROTEOMICS TO THE DIAGNOSIS AND TREATMENT OF ALS AND RELATED DISEASES
Robert Bowser et al.
MUSCLE & NERVE (2009)
The PedsQL™ in pediatric patients with Spinal Muscular Atrophy: Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory™ Generic Core Scales and Neuromuscular Module
Susan T. Iannaccone et al.
NEUROMUSCULAR DISORDERS (2009)
Phase II Open Label Study of Valproic Acid in Spinal Muscular Atrophy
Kathryn J. Swoboda et al.
PLOS ONE (2009)
The insulin paradox: aging, proteotoxicity and neurodegeneration
Ehud Cohen et al.
NATURE REVIEWS NEUROSCIENCE (2008)
Daily salbutamol in young patients with SMA type II
Marika Pane et al.
NEUROMUSCULAR DISORDERS (2008)
Modeling Spinal Muscular Atrophy in Drosophila
Howard Chia-Hao Chang et al.
PLOS ONE (2008)
Decreased serum endoglin level in patients with amyotrophic lateral sclerosis: a preliminary report
J. Ilzecka
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2008)
An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patients
Jessica M. O'Hagen et al.
NEUROMUSCULAR DISORDERS (2007)
Congenital bone fractures in spinal muscular atrophy: Functional role for SMN protein in bone remodeling
Srinivasan Shanmugarajan et al.
JOURNAL OF CHILD NEUROLOGY (2007)
A modified Hammersmith functional motor scale for use in multi-center research on spinal muscular atrophy
Kristin J. Krosschell et al.
NEUROMUSCULAR DISORDERS (2006)
The gross motor function measure™ is a valid and sensitive outcome measure for spinal muscular atrophy
Leslie Nelson et al.
NEUROMUSCULAR DISORDERS (2006)
Plasma and cerebrospinal fluid-based protein biomarkers for motor neuron disease
Christi Kolarcik et al.
MOLECULAR DIAGNOSIS & THERAPY (2006)
Bone morphogenetic protein signalling and vertebrate nervous system development
AM Liu et al.
NATURE REVIEWS NEUROSCIENCE (2005)
Genetics of leptin and obesity: A HuGE review
V Paracchini et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2005)
Pilot trial of phenylbutyrate in spinal muscular atrophy
E Mercuri et al.
NEUROMUSCULAR DISORDERS (2004)
The Hammersmith functional motor scale for children with spinal muscular atrophy: a scale to test ability and monitor progress in children with limited ambulation
M Main et al.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2003)
Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle
JN Haslett et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Motor unit number estimation in infants and children with spinal muscular atrophy
MB Bromberg et al.
MUSCLE & NERVE (2002)
A placebo-controlled trial of gabapentin in spinal muscular atrophy
RG Miller et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2001)
Quantitative analysis of gene expression in human articular cartilage from normal and osteoarthritic joints
I Martin et al.
OSTEOARTHRITIS AND CARTILAGE (2001)
Prospective analysis of strength in spinal muscular atrophy
ST Iannaccone et al.
JOURNAL OF CHILD NEUROLOGY (2000)
分享论文
